Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Bowyer PW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aguirre-Botero MC; Institut Pasteur, Université Paris Cité, Malaria Infection and Immunity, BioSPC, F-75015, Paris, France., Wang LT; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Formaglio P; Institut Pasteur, Université Paris Cité, Malaria Infection and Immunity, BioSPC, F-75015, Paris, France., Aliprandini E; Institut Pasteur, Université Paris Cité, Malaria Infection and Immunity, BioSPC, F-75015, Paris, France., Thiberge JM; Institut Pasteur, Université Paris Cité, Malaria Infection and Immunity, BioSPC, F-75015, Paris, France., Schön A; Department of Biology, Johns Hopkins University, Baltimore, MD, 21218, USA., Flores-Garcia Y; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA., Mathis-Torres S; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA., Flynn BJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., da Silva Pereira L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Le Duff Y; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Blanche Lane, South Mimms, Potters Bar, EN6 3QG, UK., Hurley M; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Blanche Lane, South Mimms, Potters Bar, EN6 3QG, UK., Nacer A; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Blanche Lane, South Mimms, Potters Bar, EN6 3QG, UK., Bowyer PW; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Blanche Lane, South Mimms, Potters Bar, EN6 3QG, UK., Zavala F; Department of Molecular Microbiology and Immunology, Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA., Idris AH; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Francica JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Seder RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: rseder@mail.nih.gov., Amino R; Institut Pasteur, Université Paris Cité, Malaria Infection and Immunity, BioSPC, F-75015, Paris, France. Electronic address: roti@pasteur.fr.
Publikováno v:
Cell reports [Cell Rep] 2023 Jul 25; Vol. 42 (7), pp. 112681. Date of Electronic Publication: 2023 Jun 28.
Autor:
Nacer A; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Kivi G; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Pert R; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Juronen E; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Holenya P; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany., Aliprandini E; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France., Amino R; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France., Silvie O; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Le Duff Y; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Hurley M; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Reimer U; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany., Tover A; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Gilbert S; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Ho MM; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Bowyer PW; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Jun 16; Vol. 12, pp. 901253. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).
Autor:
Ragotte RJ; Department of Biochemistry, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK., Pulido D; Department of Biochemistry, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK., Lias AM; Department of Biochemistry, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK., Alanine DGW; Department of Biochemistry, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK., Jamwal A; Department of Biochemistry, University of Oxford, Oxford, UK., Davies H; Department of Biochemistry, University of Oxford, Oxford, UK.; Jenner Institute, University of Oxford, Oxford, UK., Nacer A; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, UK., Lowe ED; Department of Biochemistry, University of Oxford, Oxford, UK., Grime GW; Surrey Ion Beam Centre, University of Surrey, Guildford, UK., Illingworth JJ; Jenner Institute, University of Oxford, Oxford, UK., Donat RF; Jenner Institute, University of Oxford, Oxford, UK., Garman EF; Department of Biochemistry, University of Oxford, Oxford, UK., Bowyer PW; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, UK., Higgins MK; Department of Biochemistry, University of Oxford, Oxford, UK. matthew.higgins@bioch.ox.ac.uk.; Kavli Institute of NanoTechnology Discovery, University of Oxford, Oxford, UK. matthew.higgins@bioch.ox.ac.uk., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, UK. simon.draper@bioch.ox.ac.uk.; Jenner Institute, University of Oxford, Oxford, UK. simon.draper@bioch.ox.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2022 Feb 17; Vol. 13 (1), pp. 933. Date of Electronic Publication: 2022 Feb 17.
Autor:
Large JM; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK. Electronic address: jonathan.large@lifearc.org., Birchall K; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Bouloc NS; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Merritt AT; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Smiljanic-Hurley E; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Tsagris DJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Wheldon MC; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Ansell KH; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Coombs PJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Kettleborough CA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Whalley D; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Osborne SA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Oct 01; Vol. 29 (19), pp. 126610. Date of Electronic Publication: 2019 Aug 09.
Autor:
Large JM; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK. Electronic address: jonathan.large@lifearc.org., Birchall K; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Bouloc NS; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Merritt AT; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Smiljanic-Hurley E; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Tsagris DJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Wheldon MC; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Ansell KH; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Coombs PJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Kettleborough CA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Whalley D; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Osborne SA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Feb 01; Vol. 29 (3), pp. 509-514. Date of Electronic Publication: 2018 Nov 20.
Autor:
Tsagris DJ; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK. Electronic address: denise.tsagris@lifearc.org., Birchall K; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Bouloc N; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Large JM; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Merritt A; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Smiljanic-Hurley E; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Wheldon M; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Ansell KH; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Kettleborough C; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Whalley D; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Osborne SA; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2018 Oct 15; Vol. 28 (19), pp. 3168-3173. Date of Electronic Publication: 2018 Aug 27.
Autor:
Ubillos I; ISGlobal, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain., Jiménez A; ISGlobal, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain., Vidal M; ISGlobal, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain., Bowyer PW; Bacteriology Division, MHRA-NIBSC, South Mimms, Potter Bars, EN6 3QG, UK., Gaur D; Laboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India., Dutta S; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Gamain B; Université Sorbonne Paris Cité, Université Paris Diderot, Inserm, INTS, Unité Biologie Intégrée du Globule Rouge UMR_S1134, Laboratoire d'Excellence GR-Ex, Paris, France., Coppel R; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, VIC, Australia., Chauhan V; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India., Lanar D; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Chitnis C; Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India., Angov E; U.S. Military Malaria Vaccine Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA., Beeson J; Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, VIC, Australia., Cavanagh D; Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, King's Buildings, Charlotte Auerbach Rd, Edinburgh, EH9 3FL, UK., Campo JJ; ISGlobal, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain., Aguilar R; ISGlobal, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain., Dobaño C; ISGlobal, Hospital Clínic-Universitat de Barcelona, Carrer Rosselló 153 (CEK Building), 08036, Barcelona, Catalonia, Spain. carlota.dobano@isglobal.org.
Publikováno v:
Malaria journal [Malar J] 2018 Jun 01; Vol. 17 (1), pp. 219. Date of Electronic Publication: 2018 Jun 01.
Autor:
Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. david.baker@lshtm.ac.uk., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Large JM; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Ansell KH; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Jiménez-Díaz MB; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., El Bakkouri M; Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College Street, Toronto, ON, Canada, M5G 1L7.; Toronto General Hospital Research Institute, 610 University Avenue, Toronto, ON, Canada, M5G 2M9., Birchall K; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Dechering KJ; TropIQ Health Sciences, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Bouloc NS; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Coombs PJ; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Whalley D; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Harding DJ; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Smiljanic-Hurley E; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Wheldon MC; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Walker EM; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Dessens JT; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Lafuente MJ; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Sanz LM; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Gamo FJ; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Ferrer SB; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Hui R; Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College Street, Toronto, ON, Canada, M5G 1L7.; Toronto General Hospital Research Institute, 610 University Avenue, Toronto, ON, Canada, M5G 2M9., Bousema T; Department of Medical Microbiology, Radboud University Medical Center, 6525 HP, Nijmegen, The Netherlands., Angulo-Barturén I; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Merritt AT; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Croft SL; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Gutteridge WE; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Kettleborough CA; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Osborne SA; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK.
Publikováno v:
Nature communications [Nat Commun] 2017 Sep 05; Vol. 8 (1), pp. 430. Date of Electronic Publication: 2017 Sep 05.
Autor:
Bryan D; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK., Silva N; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK., Rigsby P; Biostatistics Group, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK., Dougall T; Biostatistics Group, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK., Corran P; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK., Bowyer PW; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK. paul.bowyer@nibsc.org., Ho MM; Bacteriology Division, MHRA-NIBSC, South Mimms, Potters Bar, Hertfordshire, EN6 3QG, UK. Mei.Ho@nibsc.org.
Publikováno v:
Malaria journal [Malar J] 2017 Aug 05; Vol. 16 (1), pp. 314. Date of Electronic Publication: 2017 Aug 05.